Literature DB >> 22914240

Tacrolimus-induced unilateral ischaemic optic neuropathy in a non-transplant patient.

Monika Gupta1, Reema Bansal, Nikhil Beke, Amod Gupta.   

Abstract

Tacrolimus is commonly used as an immunosuppressant in organ transplantation. Although it is well tolerated, visual loss has been known as a rare but serious complication of this drug. We report a woman developing visual complaints while on tacrolimus therapy for nephrotic syndrome. Omission of the drug led to partial visual field recovery. Visual complications in patients receiving tacrolimus should alert the treating physicians for timely discontinuation of the drug.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22914240      PMCID: PMC4544422          DOI: 10.1136/bcr-2012-006718

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Tacrolimus.

Authors:  D B Lake; T R G Poole
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

2.  Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation.

Authors:  L A Shutter; J P Green; N J Newman; M A Hooks; R D Gordon
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

3.  Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation.

Authors:  S M Devine; N J Newman; J L Siegel; G J Joseph; T C Geis; J A Schneider; R B Geller; J R Wingard
Journal:  Bone Marrow Transplant       Date:  1996-09       Impact factor: 5.483

4.  Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation.

Authors:  R E Steg; A Kessinger; Z K Wszolek
Journal:  Bone Marrow Transplant       Date:  1999-05       Impact factor: 5.483

5.  Bilateral ischemic optic neuropathy in a patient using tacrolimus (FK506) after liver transplantation.

Authors:  Jaeha Yun; Kyung-Ah Park; Sei Yeul Oh
Journal:  Transplantation       Date:  2010-06-27       Impact factor: 4.939

6.  A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation.

Authors:  P W Brazis; J R Spivey; J P Bolling; J L Steers
Journal:  Am J Ophthalmol       Date:  2000-04       Impact factor: 5.258

7.  Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen.

Authors:  Laurence Kessler; Catalina Lucescu; Michel Pinget; Marie Noelle Charton; Veronique Mutschler; Philippe Wolf; Thierry Berney; Pierre Yves Benhamou
Journal:  Transplantation       Date:  2006-02-27       Impact factor: 4.939

8.  Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome.

Authors:  Kim Loeffler; Manjula Gowrishankar; Verna Yiu
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

9.  Acute tacrolimus toxicity in a non-transplant patient.

Authors:  Ayrn D O'Connor; Daniel E Rusyniak; James Mowry
Journal:  Clin Toxicol (Phila)       Date:  2008-11       Impact factor: 4.467

  9 in total
  5 in total

1.  Bilateral Inflammatory Optic Neuropathy Related to Graft versus Host Disease Following Allogeneic Bone Marrow Transplantation for Hodgkin Disease.

Authors:  I Moesen; D P Kidd
Journal:  Neuroophthalmology       Date:  2014-07-22

2.  Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation.

Authors:  Boyu Yang; Shaowen Wu; Shanshan Yu; Xiaoling Liang; Qifa Liu; Fen Huang; Lingyi Liang
Journal:  Eye (Lond)       Date:  2022-09-17       Impact factor: 4.456

3.  Tacrolimus Optic Neuropathy Mimicking Papilledema.

Authors:  Isra M Hussein; Jonathan A Micieli
Journal:  Case Rep Ophthalmol       Date:  2022-05-10

4.  Intracranial hypertension presenting with severe visual failure, without concurrent headache, in a child with nephrotic syndrome.

Authors:  Madeleine Barnett; Manish D Sinha; Danny Morrison; Ming Lim
Journal:  BMC Pediatr       Date:  2013-10-10       Impact factor: 2.125

5.  Retinal changes in solid organ and bone marrow transplantation patients.

Authors:  Fernando Korn Malerbi; Sergio Henrique Teixeira; Luis Gustavo Gondo Hirai; Nilson Hideo Matsudo; Adriano Biondi Monteiro Carneiro
Journal:  Einstein (Sao Paulo)       Date:  2017 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.